-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Bristol-Myers Squibb, Lowers Price Target to $66

Benzinga·07/10/2026 18:02:30
Listen to the news
B of A Securities analyst Tim Anderson maintains Bristol-Myers Squibb (NYSE:BMY) with a Buy and lowers the price target from $67 to $66.